Skip to main content
TipRanks
Go Ultimate75% OFF

Yarrow Bioscience (YARW) Income Statement

1,905 Followers

Yarrow Bioscience Income Statement

Last quarter (Q3 2026), Yarrow Bioscience's total revenue was $0.00, a decrease of 100.00% from the same quarter last year. In Q3, Yarrow Bioscience's net income was $-9.72M. See Yarrow Bioscience’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 570.00K$ 501.00K$ 424.00K$ 477.00K$ 931.00K
$ 547.00K$ 501.00K$ 424.00K$ 477.00K$ 931.00K
$ 30.30M$ 44.14M$ 29.68M$ 34.77M$ 39.84M
Depreciation and Amortization$ 23.00K$ 4.00K$ 0.00$ 72.00K$ 109.00K
$ -26.71M$ -39.80M$ -27.87M$ -33.86M$ -38.04M
$ -29.75M$ -43.64M$ -29.26M$ -34.30M$ -38.91M
$ 3.02M$ 3.83M$ 1.39M$ 363.00K$ -4.85M
$ -26.73M$ -39.80M$ -27.87M$ -33.93M$ -43.76M
$ -26.48M$ -39.83M$ -28.45M$ -23.21M$ -73.33M
Per Share Metrics
Basic EPS$ -30.96$ -46.77$ -138.48$ -566.98$ -1282.44
Diluted EPS$ -30.96$ -46.77$ -138.48$ -566.98$ -1282.44
Weighted Average Shares Outstanding855.36K851.78K205.46K63.72K57.18K
Weighted Average Shares Outstanding (Diluted)855.36K851.78K205.46K63.72K57.18K

Currency in USD

Yarrow Bioscience Earnings and Revenue History

-300M-150M0150M-18000 %-12000 %-6000 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin